VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Age 18 or older                                    │ Age 18 or older                                    │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Willing and able to comply with the study          │ Willing and able to comply with the study          │     100 │
│ procedures and provide written informed consent to │ procedures and provide written informed consent to │         │
│ participate in the study                           │ participate in the study                           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Diagnosis of probable pancreatic cancer, distal    │ Diagnosis of probable pancreatic cancer, distal    │     100 │
│ common bile duct (CBD) cholangiocarcinoma and      │ common bile duct (CBD) cholangiocarcinoma and      │         │
│ other periampullary cancers (histology not         │ other periampullary cancers (histology not         │         │
│ required)                                          │ required)                                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Biliary obstructive symptoms or signs              │ Biliary obstructive symptoms or signs              │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Bilirubin level at/above 100 umol per liter (5.8   │ Bilirubin level at/above 100 umol per liter (5.8   │     100 │
│ mg/dL)                                             │ mg/dL)                                             │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Distal biliary obstruction consistent with         │ Distal biliary obstruction consistent with         │     100 │
│ pancreatic cancer, distal CBD cholangiocarcinoma   │ pancreatic cancer, distal CBD cholangiocarcinoma   │         │
│ or other periampullary malignancy                  │ or other periampullary malignancy                  │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Location of distal biliary obstruction is such     │ Location of distal biliary obstruction is such     │     100 │
│ that it would allow the proximal end of a stent to │ that it would allow the proximal end of a stent to │         │
│ be positioned at least 2cm from the hilum          │ be positioned at least 2cm from the hilum          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients deemed as resectable by pancreatic        │ Patients deemed as resectable by pancreatic        │     100 │
│ protocol CT or MRI                                 │ protocol CT or MRI                                 │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Surgical candidate per pancreatobiliary surgeon    │ Surgical candidate per pancreatobiliary surgeon    │     100 │
│ after multi-disciplinary discussion                │ after multi-disciplinary discussion                │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Surgery intent within 4 weeks                      │ Surgery intent within 4 weeks                      │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Endoscopic and surgical treatment to be provided   │ Endoscopic and surgical treatment to be provided   │     100 │
│ by same team                                       │ by same team                                       │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Biliary strictures caused by confirmed benign      │ Biliary strictures caused by confirmed benign      │     100 │
│ tumors                                             │ tumors                                             │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Biliary strictures caused by malignancies other    │ Biliary strictures caused by malignancies other    │     100 │
│ than pancreatic cancer, distal CBD                 │ than pancreatic cancer, distal CBD                 │         │
│ cholangiocarcinoma and other periampullary cancers │ cholangiocarcinoma and other periampullary cancers │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Surgically altered biliary tract anatomy, not      │ Surgically altered biliary tract anatomy, not      │     100 │
│ including prior cholecystectomy                    │ including prior cholecystectomy                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Neoadjuvant chemotherapy for current malignancy    │ Neoadjuvant chemotherapy for current malignancy    │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Palliative indication due to reasons other than    │ Palliative indication due to reasons other than    │     100 │
│ surgical candidate status                          │ surgical candidate status                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Previous biliary drainage by ERCP/PTC              │ Previous biliary drainage by ERCP/PTC              │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients for whom endoscopic techniques are        │ Patients for whom endoscopic techniques are        │     100 │
│ contraindicated                                    │ contraindicated                                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Participation in another investigational trial     │ Participation in another investigational trial     │     100 │
│ within 90 days                                     │ within 90 days                                     │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Pregnancy                                          │ Pregnancy                                          │     100 │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤═══════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                 │   Score │
╞═══════════════════════════════════╪═══════════════════════════════╪═════════╡
│ Must have minimum age of 18 Years │ Surgery intent within 4 weeks │      35 │
╘═══════════════════════════════════╧═══════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 99
Average Levenshtein Ratio of individual lines: 96.9047619047619
OverAll Ratio: 97.95238095238095
